المؤلفون: Cucci M. A., Grattarola M., Monge C., Roetto A., Barrera G., Caputo E., Dianzani C., Pizzimenti S.

المساهمون: Cucci M.A., Grattarola M., Monge C., Roetto A., Barrera G., Caputo E., Dianzani C., Pizzimenti S.

مصطلحات موضوعية: A375 cell line, BRAFi/MEKi, D4M cell line, DUB3, Nrf2, YAP, dabrafenib, melanoma, targeted therapy resistance, trametinib

Relation: info:eu-repo/semantics/altIdentifier/pmid/37372043; info:eu-repo/semantics/altIdentifier/wos/WOS:001016848000001; volume:12; issue:6; firstpage:1313; lastpage:1336; numberofpages:24; journal:ANTIOXIDANTS; https://hdl.handle.net/2318/1923070; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85163850577

الاتاحة: https://hdl.handle.net/2318/1923070
https://doi.org/10.3390/antiox12061313